Dr. Peter Fattal, MD
Claim this profileSt. Mary's of Ascension Research
Studies Cardiovascular Disease
Studies Tricuspid Regurgitation
3 reported clinical trials
4 drugs studied
Affiliated Hospitals
Clinical Trials Peter Fattal, MD is currently running
Inclisiran
for Cardiovascular Disease
This trial is testing inclisiran, an injectable drug, on people with heart disease who are already on strong cholesterol-lowering medications. The goal is to see if inclisiran can further reduce the risk of heart attacks and strokes by lowering bad cholesterol levels. Participants will receive the injection periodically. Inclisiran works by significantly reducing bad cholesterol levels.
Recruiting1 award Phase 33 criteria
Edwards PASCAL System
for Tricuspid Regurgitation
This trial tests a new device that fixes a leaky heart valve without surgery in patients who are too risky for traditional surgery. The device helps the valve close properly to stop blood from leaking backward. The first device specifically designed for this purpose is the paravalvular leak device (PLD - Occlutech).
Recruiting1 award N/A6 criteria
More about Peter Fattal, MD
Clinical Trial Related2 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Peter Fattal, MD has experience with
- Edwards PASCAL System
- Optimal Medical Therapy
- Pelacarsen (TQJ230)
- Inclisiran
Breakdown of trials Peter Fattal, MD has run
Cardiovascular Disease
Tricuspid Regurgitation
Tricuspid Valve Disease
Atherosclerosis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Peter Fattal, MD specialize in?
Peter Fattal, MD focuses on Cardiovascular Disease and Tricuspid Regurgitation. In particular, much of their work with Cardiovascular Disease has involved treating patients, or patients who are undergoing treatment.
Is Peter Fattal, MD currently recruiting for clinical trials?
Yes, Peter Fattal, MD is currently recruiting for 2 clinical trials in Saginaw Michigan. If you're interested in participating, you should apply.
Are there any treatments that Peter Fattal, MD has studied deeply?
Yes, Peter Fattal, MD has studied treatments such as Edwards PASCAL System, Optimal Medical Therapy, Pelacarsen (TQJ230).
What is the best way to schedule an appointment with Peter Fattal, MD?
Apply for one of the trials that Peter Fattal, MD is conducting.
What is the office address of Peter Fattal, MD?
The office of Peter Fattal, MD is located at: St. Mary's of Ascension Research, Saginaw, Michigan 48601 United States. This is the address for their practice at the St. Mary's of Ascension Research.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.